UPDATED Mar 13, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
973 | HK$30.50 | 4.1% | 60.5% | HK$45.0b | HK$29.63 | PE60.2x | E29.3% | 0.8% | ||
2367 | HK$41.95 | 18.2% | -19.8% | HK$39.2b | HK$48.93 | PE35.8x | E25.1% | n/a | ||
1044 | HK$25.10 | 8.7% | -28.3% | HK$29.1b | HK$34.81 | PE14.3x | E14.3% | 6.1% | ||
3331 | HK$23.50 | 0.4% | 16.9% | HK$28.2b | HK$21.62 | PE111.7x | E38.8% | 0% | ||
2145 | HK$46.50 | 2.4% | 71.9% | HK$18.7b | HK$45.15 | PE93.1x | E47.0% | 0.9% | ||
6993 | HK$1.82 | -2.7% | -59.6% | HK$10.9b | HK$2.96 | PE18x | E10.9% | 9.2% | ||
6896 | HK$3.75 | -1.3% | 44.2% | HK$2.8b | n/a | PE7.4x | n/a | 9.1% | ||
6601 | HK$1.50 | 5.6% | -15.3% | HK$2.0b | HK$2.33 | PE16.5x | E14.3% | 4.6% | ||
157 | HK$0.50 | 0% | 0% | HK$1.0b | n/a | PS3x | n/a | 0% | ||
3828 | HK$0.68 | 1.5% | 4.6% | HK$499.3m | n/a | PE5.8x | n/a | 7.4% | ||
2023 | HK$1.00 | 3.1% | 8.7% | HK$477.0m | n/a | PE14.7x | n/a | n/a | ||
2222 | HK$0.86 | 0% | 10.3% | HK$436.3m | n/a | PB0.1x | n/a | 0% | ||
3332 | HK$0.40 | -3.6% | 215.0% | HK$354.9m | n/a | PE18.6x | n/a | 0% | ||
1962 | HK$0.51 | 2.0% | -1.9% | HK$354.1m | HK$1.75 | PE4.7x | n/a | 16.5% | ||
6893 | HK$0.31 | 3.3% | -21.5% | HK$338.5m | n/a | PS3.6x | n/a | 0% | ||
8512 | HK$0.23 | -6.0% | 54.6% | HK$270.6m | n/a | PE1.8x | n/a | n/a | ||
1455 | HK$0.18 | 1.7% | -24.6% | HK$235.3m | n/a | PE5.6x | n/a | 8.2% | ||
932 | HK$0.053 | 6.0% | -25.4% | HK$170.9m | n/a | PE5x | n/a | 0% | ||
8281 | HK$0.17 | 0% | 0% | HK$170.0m | n/a | PE10x | n/a | 3.2% | ||
1259 | HK$0.075 | 19.0% | 25.0% | HK$156.1m | n/a | PB0.3x | n/a | 0% | ||
943 | HK$0.011 | 10.0% | n/a | HK$153.9m | n/a | PB0.5x | n/a | n/a | ||
1338 | HK$0.048 | 9.1% | -11.1% | HK$145.5m | n/a | PE109.5x | n/a | n/a | ||
8436 | HK$0.22 | -3.5% | -6.8% | HK$84.0m | n/a | PE9.9x | n/a | n/a |